BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37148203)

  • 1. Evidence of inter- and intra-keloid heterogeneity through analysis of dermal fibroblasts: A new insight in deciphering keloid physiopathology.
    Serror K; Ferrero L; Boismal F; Sintes M; Thery M; Vianay B; Henry E; Gentien D; DE LA Grange P; Boccara D; Mimoun M; Bouaziz JD; Benssussan A; Michel L
    Exp Dermatol; 2023 Jul; 32(7):1096-1107. PubMed ID: 37148203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
    Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
    J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic and keloid scars fail to progress from the CD34
    Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstructed human keloid models show heterogeneity within keloid scars.
    Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
    Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
    Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.
    Yu H; Bock O; Bayat A; Ferguson MW; Mrowietz U
    J Plast Reconstr Aesthet Surg; 2006; 59(3):221-9. PubMed ID: 16676428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy.
    Zhang X; Wu X; Li D
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin (FN) in hypertrophic scars and keloids.
    Kischer CW; Hendrix MJ
    Cell Tissue Res; 1983; 231(1):29-37. PubMed ID: 6342808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
    Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
    J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression.
    Liu L; Yu H; Long Y; You Z; Ogawa R; Du Y; Huang C
    FASEB J; 2021 Jul; 35(7):e21705. PubMed ID: 34105826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars.
    Nakaoka H; Miyauchi S; Miki Y
    Acta Derm Venereol; 1995 Mar; 75(2):102-4. PubMed ID: 7604635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures.
    Abergel RP; Pizzurro D; Meeker CA; Lask G; Matsuoka LY; Minor RR; Chu ML; Uitto J
    J Invest Dermatol; 1985 May; 84(5):384-90. PubMed ID: 3998489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D modeling of keloid scars in vitro by cell and tissue engineering.
    Suttho D; Mankhetkorn S; Binda D; Pazart L; Humbert P; Rolin G
    Arch Dermatol Res; 2017 Jan; 309(1):55-62. PubMed ID: 27942931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Superficial Dermis May Initiate Keloid Formation: Histological Analysis of the Keloid Dermis at Different Depths.
    Jiao H; Zhang T; Fan J; Xiao R
    Front Physiol; 2017; 8():885. PubMed ID: 29163221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures.
    Ala-Kokko L; Rintala A; Savolainen ER
    J Invest Dermatol; 1987 Sep; 89(3):238-44. PubMed ID: 3624897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of bone/cartilage-associated genes and core transcription factors in keloids by RNA sequencing.
    Lin P; Zhang G; Peng R; Zhao M; Li H
    Exp Dermatol; 2022 Oct; 31(10):1586-1596. PubMed ID: 35730251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.